1. Giunta S. Exploring the complex relations between inflammation and aging (inflamm-aging): anti-inflamm-aging remodelling of inflamm-aging, from robustness to frailty. Inflammation research: official journal of the European Histamine Research Society [et al] 2008; 57(12): 558-63.
2. Bally M, Dendukuri N, Rich B, et al. Risk of acute myocardial infarction with NSAIDs in real world use: bayesian meta-analysis of individual patient data. BMJ (Clinical research ed) 2017; 357: j1909.
3. Fukushi K, Tominaga K, Nagashima K, et al. Gastroduodenal ulcer bleeding in elderly patients on low dose aspirin therapy. World journal of gastroenterology 2018; 24(34): 3908-18.
4. Bally M, Beauchamp ME, Abrahamowicz M, Nadeau L, Brophy JM. Risk of acute myocardial infarction with real-world NSAIDs depends on dose and timing of exposure. Pharmacoepidemiology and drug safety 2018; 27(1): 69-77.
5. Dugas B. Lyprinol inhibits LTB4 production by human monocytes. Allerg Immunol (Paris) 2000; 32(7): 284-9.
6. McPhee S, Hodges LD, Wright PF, et al. Anti-cyclooxygenase effects of lipid extracts from the New Zealand Green-shell mussel, Perna canaliculus. Comparative biochemistry and physiology Part B, Biochemistry & molecular biology 2007; 146(3): 346-56.
7. Lee CH, Butt YK, Wong MS, Lo SC. A lipid extract of Perna canaliculus affects the expression of pro-inflammatory cytokines in a rat adjuvant-induced arthritis model. Eur Ann Allergy Clin Immunol 2008; 40(4): 148-53.
8. Singh M, Hodges LD, Wright PF, et al. The CO(2)-SFE crude lipid extract and the free fatty acid extract from Perna canaliculus have anti-inflammatory effects on adjuvant induced arthritis in rats. Comparative biochemistry and physiology Part B, Biochemistry & molecular biology 2008; 149(2): 251-8.
9. Whitehouse MW, Macrides TA, Kalafatis N, Betts WH, Haynes DR, Broadbent J. Anti-inflammatory activity of a lipid fraction (Lyprinol) from the NZ Green-shell mussel. Inflammopharmacology 1997; 5(3): 237-46.
10. Szechinski J. Measurement of pain relief resulting from administration of Perna canaliculus lipid complex PCSO-524T compared with fish oil for treating patients who suffer from osteoarthritis of the knee and/or the hip joints. Reumatologia 2011; 49(4): 244-52.
11. Pumpa KL, Fallon KE, Bensoussan A, Papalia S. The effects of Lyprinol((R)) on delayed onset muscle soreness and muscle damage in well trained athletes: A double-blind randomised controlled trial. Complementary therapies in medicine 2011; 19(6): 311-8.
12. Gruenwald J, Graubaum HJ, Hansen K, Grube B. Efficacy and tolerability of a combination of Lyprinol and high concentrations of EPA and DHA in inflammatory rheumatoid disorders. Advances in therapy 2004; 21(3): 197-201.
13. Mickleborough TD, Sinex JA, Platt D, Chapman RF, Hirt M. The effects PCSO-524(R), a patented marine oil lipid and omega-3 PUFA blend derived from the New Zealand green lipped mussel (Perna canaliculus), on indirect markers of muscle damage and inflammation after muscle damaging exercise in untrained men: a randomized, placebo controlled trial. Journal of the International Society of Sports Nutrition 2015; 12:10.
14. Kean JD, Camfield D, Sarris J, et al. A randomized controlled trial investigating the effects of PCSO-524(R), a patented oil extract of the New Zealand green lipped mussel (Perna canaliculus), on the behaviour, mood, cognition and neurophysiology of children and adolescents (aged 6-14 years) experiencing clinical and sub-clinical levels of hyperactivity and inattention: study protocol ACTRN12610000978066. Nutrition journal 2013; 12(1): 100.
15. Lau CS, Chiu PKY, Chu EMY, et al. Treatment of knee osteoarthritis with Lyprinol, lipid extract of the Green-shell mussel - A double-blind placebo-controlled study. Prog Nutr 2004; 6(1): 17-31.
16. Atkinson A, Siegel V, Pakhomov EA, Jessop MJ, Loeb V. A re-appraisal of the total biomass and annual production of Antarctic krill. Deep-Sea Research 1 2009; 56(5): 727-40.
17. Krill fisheries and sustainability. 2018. https://www.ccamlr.org/en/fisheries/krill-fisheries-and-sustainability2019).
18. Major win! Krill industry backs Antarctic Ocean sanctuaries. 2018. https://www.greenpeace.org.uk/krill-industry-backs-antarctic-ocean-sanctuary/2019).
19. Sung HH, Sinclair AJ, Lewandowski PA, Su XQ. Postprandial long-chain n-3 polyunsaturated fatty acid response to krill oil and fish oil consumption in healthy women: a randomised controlled, single-dose, crossover study. Asia Pacific journal of clinical nutrition 2018; 27(1): 148-57.
20. Rundblad A, Holven KB, Bruheim I, Myhrstad MC, Ulven SM. Effects of fish and krill oil on gene expression in peripheral blood mononuclear cells and circulating markers of inflammation: a randomised controlled trial. Journal of nutritional science 2018; 7: e10.
21. Cicero AF, Rosticci M, Morbini M, et al. Lipid-lowering and anti-inflammatory effects of omega 3 ethyl esters and krill oil: a randomized, cross-over, clinical trial. Archives of medical science : AMS 2016; 12(3): 507-12.
22. Kishimoto Y, Yoshida H, Kondo K. Potential anti-atherosclerotic properties of astaxanthin. Marine drugs 2016; 14(2).
23. Burri L, Johnsen L. Krill products: An overview of animal studies. Nutrients 2015; 7(5): 3300-21.
24. Suzuki Y, Fukushima M, Sakuraba K, Sawaki K, Sekigawa K. Krill oil improves mild knee joint pain: A randomized control trial. PloS one 2016; 11(10): e0162769.
25. Biavatti MW. Synergy: an old wisdom, a new paradigm for pharmacotherapy. Brazilian Journal of Pharmaceutical Sciences 2009; 45(3): 371-8.
26. Ghimire K, Altmann HM, Straub AC, Isenberg JS. Nitric oxide: what’s new to NO? American journal of physiology Cell physiology 2017; 312(3): C254-c62.
27. Coleman JW. Nitric oxide in immunity and inflammation. International immunopharmacology 2001; 1(8): 1397-406.
28. Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls. Cell 1994; 78(6): 915-8.
29. Stuehr DJ, Marletta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proceedings of the National Academy of Sciences of the United States of America 1985; 82(22): 7738-42.
30. Vannini F, Kashfi K, Nath N. The dual role of iNOS in cancer. Redox biology 2015; 6: 334-43.
31. Mehta AK, Gracias DT, Croft M. TNF activity and T cells. Cytokine 2018; 101: 14-8.
32. Swardfager W, Lanctot K, Rothenburg L, Wong A, Cappell J, Herrmann N. A meta-analysis of cytokines in Alzheimer’s disease. Biological psychiatry 2010; 68(10): 930-41.
33. Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biological psychiatry 2010; 67(5): 446-57.
34. Cairns CB, Panacek EA, Harken AH, Banerjee A. Bench to bedside: tumor necrosis factor-alpha: from inflammation to resuscitation. Academic emergency medicine : official journal of the Society for Academic Emergency Medicine 2000; 7(8): 930-41.
35. Narazaki M, Kishimoto T. The two-faced cytokine IL-6 in host defense and diseases. International journal of molecular sciences 2018;19(11).
36. Banks WA, Kastin AJ, Gutierrez EG. Penetration of interleukin-6 across the murine blood-brain barrier. Neuroscience letters 1994; 179(1-2): 53-6.